Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido; North Central Cancer Treatment Group protocol N02C3. Barton, Debra L , Wender, Donald B , Sloan, Jeff A , Dalton, Robert J ... - - J. Natl. Cancer Inst. - 2007 Manuscript - Primary - Primary - Symptom Inter - NCCTG-N02C3
Salvage chemotherapy with rituximab DHAP for relapsed non-Hodgkin lymphoma: A phase II trial in the North Central Cancer Treatment Group Witzig, Thomas E. , Geyer, Susan M. , Kurtin, Paul J. ... - - Leuk. Lymphoma - 2008 Manuscript - Primary - Primary - Lymphoma - N9981